Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Nutech Mediworld, the world’s only human embryonic stem cell therapy centre based in India, announced that its human embryonic stem cell (hESC) technology developed by Dr Geeta Shroff has received 66th patent in Malaysia for the treatment of various medical conditions.  
    The technology differentiates itself from other stem cell therapies in three major ways. Firstly, it has universal application, i.e. anyone and everyone can take these cells without the need for matching. Secondly, it is available in a ready to use form with a shelf life of 6 months &  can be transported easily. Thus is not clinic based. Thirdly, it has an easy non-invasive delivery mechanism and can be administered in the simple form of an injection. Due to these qualities it has the potential to be made readily available in pharmacies across the world, much like insulin.

    [adsense:336x280:8701650588]

  • The European Food Standards Authority has warned that people who eat a lot of rice, are exposed to worrying concentrations. Chronic exposure to inorganic arsenic has been linked to developmental problems, heart disease, diabetes, nervous system damage, and cancer. Researchers in Northern Ireland have now found a way to remove the inorganic arsenic by cooking rice the way coffee is brewed.

  • In a finding that could lead to the first effective therapies and vaccines against dengue, scientists have determined the structure of a human antibody which can fight the deadly virus. Researchers at Vanderbilt University and the National University of Singapore determined the structure of the human monoclonal antibody which, in an animal model, strongly neutralises a type of the potentially lethal dengue virus.

  • Karim Mekhail, a professor at the University of Toronto has revealed how a damaged DNA is transported within a cell and repaired. By using yeast cells, researchers discovered the DNA ambulance, which is a motor protein complex.

  • Study find a metabolic imbalance caused by radiation from your wireless devices could be the link to a number of health risks, such as various neurodegenerative diseases and cancer. This imbalance, also known as oxidative stress, is defined as "an imbalance between the production of reactive oxygen species (ROS) and antioxidant defense". The study  published in the journal Electromagnetic Biology & Medicine.

  • Medical researchers at the University of Freiburg have claimed that fish toxin could be used as a potential medication for cancer. The Yersinia species of pathogens can cause the bubonic plague and serious gastrointestinal infections in humans. The study has been published in the journal Nature Communications.

  • The way children sniff different aromas could form the basis of a test to accurately detect autism, a new study has found. Researchers have found that autistic children go right on sniffing in the same way, no matter how pleasant or awful the scent is. The findings suggest that non-verbal tests related to smell might serve as useful early indicators of autism spectrum disorder (ASD), the researchers said.

  • A drug to treat diabetes can help obese people who don't have the disease lose weight and keep it off, a new study has found. Researchers found that 63 per cent of study participants given the drug liraglutide for 56 weeks lost at least 5 per cent of their body weight whereas just 27 per cent of the placebo group lost that much.

  • Researchers discovered that ethoxzolamide, a sulfa-based compound found in many prescription glaucoma drugs, actually turns off the bacterium's ability to invade the immune system.  In a breakthrough discovery, Robert Abramovitch, a Michigan State University microbiologist, along with a graduate student have suggested that a common medication used to treat glaucoma could also be used to treat tuberculosis (TB). The study has been published in Antimicrobial Agents and Chemotherapy.

Subscribe to Pharma News